As such, the reductions of 5HT and melatonin, which influence mood and have broader consequences on clinical progression in MS, can be recognised as a secondary consequence of KP activation that can be induced through the shared inflammatory mediators in depression and MS. This evidence concerns the gene NPPA and depressive disorder.